Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Operations Statements (unaudited)

v3.19.2
Condensed Consolidated Operations Statements (unaudited) - USD ($)
3 Months Ended
Jul. 31, 2019
Jul. 31, 2018
REVENUES    
Revenue
Total Revenue
EXPENSES    
Research and development 185,695 107,668
Payroll expense 7,137 33,546
Professional fees 105,696 3,973
General and administrative expenses 22,974 1,264
Loss before income taxes (321,502) (146,450)
Provision for income taxes
NET LOSS $ (321,502) $ (146,450)
LOSS PER SHARE - basic and diluted $ (0.89) $ (0.82)
Weighted average shares outstanding - basic and diluted 359,715 179,110